Clinical Trial Update: Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali [Phase 1]

View source ↗

Summary

A Phase 1 study of the malaria transmission-blocking vaccine Pfs230D1-EPA/Matrix-M in adults in Mali has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• Pfs230D1-EPA/Matrix-M

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria,Falciparum | Phase 1 | Status: COMPLETED | Results posted: 2024-05-06